Cat.#: ACPP-1351
| Despition | Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
| ACPP-1837 | Rat SCGN Protein (AC1837) | 2 µg | inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg | inquiry |
| ACPP-1104 | Human IL 6 Protein (AC1104) | 5 µg | inquiry |
| ACPP-1217 | P2Y2 Blocking Peptide (AC1217) | 250 µg | inquiry |
| ACPP-1241 | Dopamine Receptor D4 Blocking Peptide (AC1241) | 250 µg | inquiry |
| ACPP-1543 | Human AKR1C3 Protein (AC1543) | 5 µg | inquiry |
| ACPP-1600 | Mouse IL 6 Protein, Sf9 (AC1600) | 2 µg | inquiry |
| ACPP-1383 | Human KLF7 Protein (AC1383) | 5 µg | inquiry |
| ACPP-1051 | Recombinant Human Amyloid Precursor Protein Protein (6×His Tag) (AC1051) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.